Paragon 28 Inc. (FNA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Paragon 28 Inc. (FNA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

10.29

-0.45 (-4.19%)

At close: Jan 14, 2025, 3:59 PM

10.28

-0.15%

After-hours Jan 14, 2025, 07:00 PM EST

undefined% (undefined)

Bid	4.12
Market Cap	861.90M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.67
PE Ratio (ttm)	-15.37
Forward PE	n/a
Analyst	Buy

Ask	15
Volume	551,838
Avg. Volume (20D)	612,629
Open	10.94
Previous Close	10.74
Day's Range	9.44 - 11.10
52-Week Range	4.65 - 14.79
Beta	undefined

About FNA

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also ...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Oct 15, 2021

Employees 574

Stock Exchange NYSE

Ticker Symbol FNA

Website https://www.paragon28.com

Analyst Forecast

According to 5 analyst ratings, the average rating for FNA stock is "Buy." The 12-month stock price forecast is $15, which is an increase of 45.70% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Paragon 28 Inc. is scheduled to release its earnings on Feb 27, 2025, during market hours.
Analysts project revenue of $68.99M, reflecting a 13.92% YoY growth and earnings per share of -0.12, making a -29.41% decrease YoY.

Why Price Moved

2 months ago · Source

+37.33%

Paragon 28 shares are trading higher following Q3 ... Unlock content with Pro Subscription

5 months ago · Source

-20.1%

Paragon 28 share are trading lower. The company reported Q2 financial results and issued FY24 guidance below estimates

News

1 week ago · businesswire.com

Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chai...

1 month ago · businesswire.com

Paragon 28 Appoints Dave Demski to Board of Directors

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independen...

1 month ago · zacks.com

Wall Street Analysts Predict a 39.67% Upside in Paragon 28, Inc. (FNA): Here's What You Should Know

The consensus price target hints at a 39.7% upside potential for Paragon 28, Inc. (FNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings e...

1 month ago · businesswire.com

FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm.